InvestorsObserver releases comments on Pfizer, FedEx, Nike, General Mills, and DR Horton

CHICAGO, Dec. 15, 2014 /PRNewswire/ -- InvestorsObserver.com releases its Stocks To Watch guide.  

To see what our analysts have discovered about these stocks read the InvestorsObserver's Stocks To Watch guide at http://www.investorsobserver.com/stw/121220140. (Note: You may have to copy this link into your browser then press the [ENTER] key.)

The following stocks are featured in the Stocks To Watch guide: Pfizer (NYSE: PFE), FedEx (NYSE: FDX), Nike (NYSE: NKE), General Mills (NYSE: GIS), and DR Horton (NYSE: DHI). 

InvestorsObserver's Stocks To Watch guide provides investors with critical information on stocks that may be poised for a significant move. Each report features our thoughts on what could happen with the stock in the near future, technical analysis, and several hedged trade ideas. We give investors the tools they need to protect their portfolios against uncertainty.

"In addition to brief stock analysis and commentary, the Stocks To Watch guide also provides several strategies and insight on how to ensure your investments are protected with basic hedging techniques," said Brent Archer, InvestorsObserver analyst. "Our guide contains information that can benefit both expert and novice investors considering these stocks."

The Stocks To Watch Guide is available to investors at http://www.investorsobserver.com/stw/121220140. (Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver.com is an online newsletter which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help subscribers make the best possible investment decisions. For more information, go to www.investorsobserver.com.

All stocks and options shown are examples only-- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security.  Potential returns do not take into account your trade size, brokerage commissions or taxes--expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available at http://www.cboe.com/Resources/Intro.aspx. Privacy policy available upon request.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/investorsobserver-releases-comments-on-pfizer-fedex-nike-general-mills-and-dr-horton-300009283.html

SOURCE InvestorsObserver

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.